研究
Serological diagnosis and monitoring of Mycobacterium avium complex lung diseases by Enzyme Immunoassay of IgA antibodies agains
日期: 2020-04-16
作者: Dr. TAM Wai On
摘要: Introduction: There is an increasing trend worldwide in the incidence of Mycobacterium avium complex pulmonary diseases (MAC-PD) and the diagnosis is sometimes complicated. Recently, an enzyme immunoassay (EIA) kit that detects serum IgA antibody against MAC-specific glycopeptidolipid (GPL) core antigen had been developed and found to be useful in discriminating MAC-PD from other lung diseases. The antibody was subsequently also found to be elevated in patients suffering Mycobacterium abscessus pulmonary diseases (MAB-PD). This study is to evaluate this EIA kit in the serological diagnosis of MAC-PD in Hong Kong Chinese patients. Methods: The study was conducted in Grantham Hospital, Hong Kong between July 2017 to July 2018. Assay of the IgA antibody level using the EIA kit was done on blood samples collected from patients suffering from MAC-PD, MAB-PD, pulmonary tuberculosis and other lung diseases. Results: There were 100 subjects recruited into the study, among which 11 were excluded. By the cut-off value set by the manufacturer, the sensitivity and specificity for diagnosis were 73.7% and 77.6% for MAC-PD; 50% and 77.6% for MAB-PD. By receiver operating characteristic curves analysis, the best cut-off for MAC-PD was 1.771 U/mL and for MAB-PD was 0.172 U/mL. Using this best cut-off, the sensitivity and specificity was 68.4% and 86.2% for MAC-PD; 66.7% and 72.4% for MAB-PD respectively. Conclusions: This study showed that measurement of IgA antibodies against MAC-specific glycopeptidolipid core antigen may be useful in the diagnosis of MAC-PD among Hong Kong Chinese patients and helped to differentiate MAB-PD from other lung diseases.
附錄二
日期: 0000-00-00
附錄一
日期: 0000-00-00
胸肺科研基金
日期: 2018-12-19
作者: 香港防癆心臟及胸病協會
摘要: 肺部是最容易受到外部環境傷害的內部器官。在香港,長者因肺部問題導致死亡的百分比一直高企。有見及此,防癆會於2013年成立了「科硏及胸肺健康委員會」,以聚集本地專業人士,鼓勵、協助並協調香港各組織和機構的科學研究,從而提高治療肺部疾病的療效。 為了鼓勵更多大規模和持續性的研究工作,我們需要您的慷慨捐助。我們承諾您的捐款將全數用於研究工作,所有行政管理費用均由防癆會承擔。 我們會一如以往,繼續努力服務市民。我們真誠希望您能支持胸肺科研基金,以提昇香港有關肺部健康硏究的領域。
報告頁面
日期: 0000-00-00
日期: 0000-00-00
中期報告
日期: 0000-00-00
申請表
日期: 0000-00-00
申請指引
日期: 0000-00-00
11 - 中国农村小区的结核潜伏感染流行病学调查和干预研究
日期: 2017-11-02
10 - 香港结核病预防及控制 - 监督治疗
日期: 2017-11-02
9 - 澳门地区结核病分子流行病学分析
日期: 2017-11-02
8 - 结核分枝杆菌基因分形技术的应用
日期: 2017-11-02
7 - 结核分枝杆菌耐药体外遗传进化
日期: 2017-11-02
6 - 结核性腰大肌脓伤
日期: 2017-11-02
5 - 上海市结核病管理信息系统与疫情分析
日期: 2017-11-02
2 - 结核病 MS管理信息系统介绍
日期: 2017-11-02
Application on GeneXpert on bronchoscopic samples in the clinical management of patients suspicious of Tuberculosis
日期: 2017-11-13
作者: Dr. TO Kin Wang
摘要: Background: There is limited experience on clinical use of GeneXpert on bronchoalveolar lavage (BAL) fluid samples obtained from patients clinically suspected of pulmonary tuberculosis (TB) in intermediate burden settings. Methods: sputum acid-fast-bacilli (AFB) smear negative patients were offered bronchoscopy. BAL fluid was collected for AFB smear, TB culture, Cobas Taqman TB polymerase chain reaction (PCR) and for GeneXpert. Cases were diagnosed as TB if any one of the tests was positive. Results: From December 2014 to February 2017, 227 samples were collected. Patients’ mean (SD) age was 60.7 (15) years, 143 patients were males and 84 were females. Cough and haemoptysis were the presenting symptoms in 70% and 37.4% respectively. Apical shadows in chest X-ray (CXR) and apical cavitations in computed tomography (CT) were more common in GeneXpert positive cases (p=0.01 and 0.02 respectively). Sensitivities and specificity of GeneXpert was 80% and 98% respectively. The positive predictive value and negative predictive value was 92.3 and 95.1% respectively. There were 9 false negative GeneXpert samples (8 were Cobas Taqman TB PCR negative): 6 were diagnosed by BAL culture, 2 by biopsy and one by Cobas Taqman TB PCR. There were 3 false positive cases with negative culture, 2 were put on empirical treatment with favorable clinical responses, while one defaulted followed up. Conclusion: GeneXpert in BAL samples has high specificity and similar performance as Cobas Taqman PCR to rule in TB for initiating early treatment in clinical suspicious cases. However, it cannot replace other investigations as the only test for diagnosing pulmonary TB.
1 - 香港特别行政区结核杆菌 / 艾滋病病毒 (TB/HIV) / 双重感染死亡个案分析
日期: 2017-11-02
Sinew Acupuncture for de Quervain's Tenosynovitis: a randomized waitlist controlled trial
日期: 2017-03-01
作者: Please refer to content
摘要: With the aim to train Chinese Medicine Practitioners in conducting scientific researches, The Hong Kong Tuberculosis Association--The University of Hong Kong Chinese Medicine Clinic cum Training and Research Centre (Southern District) participated in a project initiated and sponsored by Hospital Authority. The project was supervised by the University of Hong Kong (HKU). It was competed in Mid 2019.
Sinew acupuncture for knee osteoarthritis: a randomized, patient- and assessor-blinded, sham-controlled trial
日期: 2017-05-01
作者: Please refer to content
摘要: With the aim to train Chinese Medicine Practitioners in conducting scientific researches, The Hong Kong Tuberculosis Association--The University of Hong Kong Chinese Medicine Clinic cum Training and Research Centre (Southern District) participated in a project initiated and sponsored by Hospital Authority. The project was supervised by the University of Hong Kong (HKU). It was competed in Late 2018.
Optimizing MGIT pyrazinamide susceptibility testing using a reduced inoculum
日期: 2016-07-31
作者: Dr. YAM Wing Cheong
摘要: Among the 150 culture isolates, 11 isolates failed in the MGIT 960 PZA susceptibility test due to under inoculums size (3 isolates for both standard and reduced inoculums; 8 isolates for reduced inoculums only). The failure rate for standard and reduced inoculums was 1.8% (3/171) and 6.4% (11/171) respectively. Only 139 isolates were eligible for further study and analysis. Another 21 archived PZA resistant strains collected between 2003-2013 were also included for comparative study. However, one strain was later confirmed to be PZA susceptible that 140 PZA susceptible and 20 PZA resistant strains were used for the McNemar’s analysis, indicating there is no significant difference between standard and reduced inoculums for MGIT960 PZA susceptibility test (p = 0.6171; Odd Ratio = 1; 95% CI: 0.072 – 13.796). The 20 PZA resistant archived strains collected between 2003-2013 were further characterized by MGIT960 PZA (standard and reduced inoculums) test, PZase activity and DNA sequencing to identify pncA mutations. The most common PZA resistant mutations at pncA were G162D and I90S. Novel mutations including insertions and deletions were also detected among PZA resistant strains. PZase activity were negative for all PZA resistant strains while 20 randomly selected PZA susceptible strains were positive to PZase activity with no mutations in the pncA gene. One strain (WC036) reported as PZA susceptible by TB Reference laboratory (PHLSB) was confirmed resistant to PZA by MGIT960 (both standard and reduced inoculum) with pncA mutations and negative for PZase activity. Another strain (WC205) reported as susceptible to all first line drugs but resistant to PZA was also confirmed susceptible to PZA by MGIT960 (both standard and reduced inoculum) with wild type pncA and positive for PZase activity. In this study, testing 160 M. tuberculosis isolates indicated no significant difference between standard and reduced inoculums for MGIT960 PZA susceptibility test (p >0.05). The failure rate for standard and reduced inoculums was 1.8% and 6.4% respectively. The 1 false susceptible and 1 false resistant isolates reported by TB reference Laboratory (PHLSB) was probably accounted by the drug susceptibility test other than MGIT960. Since 2014, PHLSB has adopted the MGIT960 system with standard inoculums size for routine service to all Hospital Authority Hospitals in Hong Kong. For routine PZA MGIT 960 susceptibility testing using standard inoculums, clinical isolates reported as resistant to PZA should be confirmed by PZase activity and pncA gene mutation analysis using PCR-sequencing.